Citation: Gd. Shanks et al., Malaria chemoprophylaxis in the age of drug resistance. II. Drugs that maybe available in the future, CLIN INF D, 33(3), 2001, pp. 381-385
Citation: Kc. Kain et al., Malaria chemoprophylaxis in the age of drug resistance. I. Currently recommended drug regimens, CLIN INF D, 33(2), 2001, pp. 226-234
Authors:
Shanks, GD
Oloo, AJ
Aleman, GM
Ohrt, C
Klotz, FW
Braitman, D
Horton, J
Brueckner, R
Citation: Gd. Shanks et al., A new primaquine analogue, tafenoquine (WR 238605), for prophylaxis against Plasmodium falciparum malaria, CLIN INF D, 33(12), 2001, pp. 1968-1974
Citation: Gd. Shanks et al., Changing patterns of clinical malaria since 1965 among a tea estate population located in the Kenyan highlands, T RS TROP M, 94(3), 2000, pp. 253-255
Authors:
Ogutu, BR
Smoak, BL
Nduati, RW
Mbori-Ngacha, DA
Mwathe, F
Shanks, GD
Citation: Br. Ogutu et al., The efficacy of pyrimethamine-sulfadoxine (Fansidar (R)) in the treatment of uncomplicated Plasmodium falciparum malaria in Kenyan children, T RS TROP M, 94(1), 2000, pp. 83-84
Citation: Gd. Shanks, New options for the prevention and treatment of malaria: Focus on the roleof atovaquone and proguanil hydrochloride, J TRAVEL M, 6, 1999, pp. S1-S1
Citation: Gd. Shanks et al., Time to reappearance of malaria parasites following various drug treatmentregimens in a holoendemic area of western Kenya, T RS TROP M, 93(3), 1999, pp. 304-305